Lactoferrin as potential preventative and adjunct treatment for COVID-19

DOI record: { "DOI": "10.1016/j.ijantimicag.2020.106118", "ISSN": [ "0924-8579" ], "URL": "http://dx.doi.org/10.1016/j.ijantimicag.2020.106118", "alternative-id": [ "S0924857920303010" ], "article-number": "106118", "assertion": [ { "label": "This article is maintained by", "name": "publisher", "value": "Elsevier" }, { "label": "Article Title", "name": "articletitle", "value": "Lactoferrin as potential preventative and adjunct treatment for COVID-19" }, { "label": "Journal Title", "name": "journaltitle", "value": "International Journal of Antimicrobial Agents" }, { "label": "CrossRef DOI link to publisher maintained version", "name": "articlelink", "value": "https://doi.org/10.1016/j.ijantimicag.2020.106118" }, { "label": "Content Type", "name": "content_type", "value": "article" }, { "label": "Copyright", "name": "copyright", "value": "© 2020 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights reserved." } ], "author": [ { "ORCID": "http://orcid.org/0000-0001-9115-7799", "affiliation": [], "authenticated-orcid": false, "family": "Chang", "given": "Raymond", "sequence": "first" }, { "affiliation": [], "family": "Ng", "given": "Tzi Bun", "sequence": "additional" }, { "affiliation": [], "family": "Sun", "given": "Wei-Zen", "sequence": "additional" } ], "container-title": "International Journal of Antimicrobial Agents", "container-title-short": "International Journal of Antimicrobial Agents", "content-domain": { "crossmark-restriction": true, "domain": [ "clinicalkey.jp", "clinicalkey.com", "clinicalkey.es", "clinicalkey.com.au", "clinicalkey.fr", "elsevier.com", "sciencedirect.com" ] }, "created": { "date-parts": [ [ 2020, 7, 30 ] ], "date-time": "2020-07-30T01:59:56Z", "timestamp": 1596074396000 }, "deposited": { "date-parts": [ [ 2021, 3, 27 ] ], "date-time": "2021-03-27T08:46:14Z", "timestamp": 1616834774000 }, "indexed": { "date-parts": [ [ 2022, 8, 3 ] ], "date-time": "2022-08-03T11:54:34Z", "timestamp": 1659527674707 }, "is-referenced-by-count": 75, "issue": "3", "issued": { "date-parts": [ [ 2020, 9 ] ] }, "journal-issue": { "issue": "3", "published-print": { "date-parts": [ [ 2020, 9 ] ] } }, "language": "en", "license": [ { "URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2020, 9, 1 ] ], "date-time": "2020-09-01T00:00:00Z", "timestamp": 1598918400000 } } ], "link": [ { "URL": "https://api.elsevier.com/content/article/PII:S0924857920303010?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://api.elsevier.com/content/article/PII:S0924857920303010?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining" } ], "member": "78", "original-title": [], "page": "106118", "prefix": "10.1016", "published": { "date-parts": [ [ 2020, 9 ] ] }, "published-print": { "date-parts": [ [ 2020, 9 ] ] }, "publisher": "Elsevier BV", "reference": [ { "DOI": "10.1056/NEJMoa2001017", "article-title": "A novel coronavirus from patients with pneumonia in China, 2019", "author": "Zhu", "doi-asserted-by": "crossref", "first-page": "727", "journal-title": "N Engl J Med", "key": "10.1016/j.ijantimicag.2020.106118_bib0001", "volume": "382", "year": "2020" }, { "DOI": "10.3892/ijmm.2020.4596", "article-title": "Towards effective COVID-19 vaccines: updates, perspectives and challenges (review)", "author": "Calina", "doi-asserted-by": "crossref", "first-page": "3", "journal-title": "Int J Mol Med", "key": "10.1016/j.ijantimicag.2020.106118_bib0002", "volume": "46", "year": "2020" }, { "DOI": "10.1002/jmv.25681", "article-title": "Emerging coronaviruses: genome structure, replication, and pathogenesis", "author": "Chen", "doi-asserted-by": "crossref", "first-page": "418", "journal-title": "J Med Virol", "key": "10.1016/j.ijantimicag.2020.106118_bib0003", "volume": "92", "year": "2020" }, { "DOI": "10.1139/o06-045", "article-title": "Interactions of lactoferrin with cells involved in immune function", "author": "Legrand", "doi-asserted-by": "crossref", "first-page": "282", "journal-title": "Biochem Cell Biol", "key": "10.1016/j.ijantimicag.2020.106118_bib0004", "volume": "84", "year": "2006" }, { "DOI": "10.3390/molecules21060752", "article-title": "Antimicrobial activity of lactoferrin-related peptides and applications in human and veterinary medicine", "author": "Bruni", "doi-asserted-by": "crossref", "first-page": "752", "journal-title": "Molecules", "key": "10.1016/j.ijantimicag.2020.106118_bib0005", "volume": "21", "year": "2016" }, { "DOI": "10.1080/22221751.2020.1736644", "article-title": "A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses", "author": "Fung", "doi-asserted-by": "crossref", "first-page": "558", "journal-title": "Emerg Microbes Infect", "key": "10.1016/j.ijantimicag.2020.106118_bib0006", "volume": "9", "year": "2020" }, { "article-title": "Lactoferrin: a general review", "author": "Levay", "first-page": "252", "journal-title": "Haematologica", "key": "10.1016/j.ijantimicag.2020.106118_bib0007", "volume": "80", "year": "1995" }, { "article-title": "The proteins in whey", "author": "Sorensen", "first-page": "55", "journal-title": "C R Trav Lab Carlsb Ser Chim", "key": "10.1016/j.ijantimicag.2020.106118_bib0008", "volume": "23", "year": "1940" }, { "DOI": "10.3891/acta.chem.scand.14-0510", "article-title": "Isolation of an iron-containing red protein from human milk", "author": "Johanson", "doi-asserted-by": "crossref", "first-page": "510", "journal-title": "Acta Chem Scand", "key": "10.1016/j.ijantimicag.2020.106118_bib0009", "volume": "14", "year": "1960" }, { "article-title": "Protective influence of lactoferrin on mice infected with the polycythemia-inducing strain of Friend virus complex", "author": "Lu", "first-page": "4184", "journal-title": "Cancer Res", "key": "10.1016/j.ijantimicag.2020.106118_bib0010", "volume": "47", "year": "1987" }, { "DOI": "10.1007/s00253-015-6818-4", "article-title": "Antiviral activities of whey proteins", "author": "Ng", "doi-asserted-by": "crossref", "first-page": "6997", "journal-title": "Appl Microbiol Biotechnol", "key": "10.1016/j.ijantimicag.2020.106118_bib0011", "volume": "99", "year": "2015" }, { "DOI": "10.1016/j.jiac.2014.08.003", "article-title": "Lactoferrin for prevention of common viral infections", "author": "Wakabayashi", "doi-asserted-by": "crossref", "first-page": "666", "journal-title": "J Infect Chemother", "key": "10.1016/j.ijantimicag.2020.106118_bib0012", "volume": "20", "year": "2014" }, { "DOI": "10.1371/journal.pone.0023710", "article-title": "Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans", "author": "Lang", "doi-asserted-by": "crossref", "first-page": "e23710", "journal-title": "PLoS One", "key": "10.1016/j.ijantimicag.2020.106118_bib0013", "volume": "6", "year": "2011" }, { "DOI": "10.1111/j.1462-5822.2004.00389.x", "article-title": "Herpes simplex virus: receptors and ligands for cell entry", "author": "Spear", "doi-asserted-by": "crossref", "first-page": "401", "journal-title": "Cell Microbiol", "key": "10.1016/j.ijantimicag.2020.106118_bib0014", "volume": "6", "year": "2004" }, { "DOI": "10.1111/j.1742-4658.2009.07400.x", "article-title": "Viral entry mechanisms: human papillomavirus and a long journey from extracellular matrix to the nucleus", "author": "Sapp", "doi-asserted-by": "crossref", "first-page": "7206", "journal-title": "FEBS J", "key": "10.1016/j.ijantimicag.2020.106118_bib0015", "volume": "276", "year": "2009" }, { "DOI": "10.1002/jmv.20171", "doi-asserted-by": "crossref", "key": "10.1016/j.ijantimicag.2020.106118_bib0016", "unstructured": "Andersen JH, Jenssen H, Sandvik K, Gutteberg TJ. Anti-HSV activity of lactoferrin and lactoferricin is dependent on the presence of heparan sulphate at the cell surface. J Med Virol200474:262–71. doi:10.1002/jmv.20171." }, { "DOI": "10.1074/jbc.M207879200", "article-title": "Identification of a lactoferrin-derived peptide possessing binding activity to hepatitis C virus E2 envelope protein", "author": "Nozaki", "doi-asserted-by": "crossref", "first-page": "10162", "journal-title": "J Biol Chem", "key": "10.1016/j.ijantimicag.2020.106118_bib0017", "volume": "278", "year": "2003" }, { "DOI": "10.1016/S1357-2725(98)00066-1", "article-title": "Antiviral effect of bovine lactoferrin saturated with metal ions on early steps of human immunodeficiency virus type 1 infection", "author": "Puddu", "doi-asserted-by": "crossref", "first-page": "1055", "journal-title": "Int J Biochem Cell Biol", "key": "10.1016/j.ijantimicag.2020.106118_bib0018", "volume": "30", "year": "1998" }, { "DOI": "10.1016/j.ctim.2012.12.006", "doi-asserted-by": "crossref", "key": "10.1016/j.ijantimicag.2020.106118_bib0019", "unstructured": "Vitetta L, Coulson S, Beck SL, Gramotnev H, Du S, Lewis S. The clinical efficacy of a bovine lactoferrin/whey protein Ig-rich fraction (Lf/IgF) for the common cold: a double blind randomized study. Complement Ther Med201321:164–71. doi:10.1016/j.ctim.2012.12.006." }, { "article-title": "Questionnaire survey on the subjective effects of a lactoferrin supplement", "author": "Oda", "first-page": "121", "journal-title": "J Jpn Soc Complement Altern Med", "key": "10.1016/j.ijantimicag.2020.106118_bib0020", "volume": "9", "year": "2012" }, { "DOI": "10.1111/j.1651-2227.2007.00393.x", "doi-asserted-by": "crossref", "key": "10.1016/j.ijantimicag.2020.106118_bib0021", "unstructured": "Egashira M, Takayanagi T, Moriuchi M, Moriuchi H. Does daily intake of bovine lactoferrin-containing products ameliorate rotaviral gastroenteritis. Acta Paediatr200796:1242–4. doi:10.1111/j.1651-2227.2007.00393.x." }, { "DOI": "10.1111/j.1440-1746.2007.04858.x", "article-title": "Effect of lactoferrin in patients with chronic hepatitis C: combination therapy with interferon and ribavirin", "author": "Kaito", "doi-asserted-by": "crossref", "first-page": "1894", "journal-title": "J Gastroenterol Hepatol", "key": "10.1016/j.ijantimicag.2020.106118_bib0022", "volume": "22", "year": "2007" }, { "DOI": "10.1038/aps.2013.200", "article-title": "Immunomodulatory effects of lactoferrin", "author": "Siqueiros-Cendón", "doi-asserted-by": "crossref", "first-page": "557", "journal-title": "Acta Pharmacol Sin", "key": "10.1016/j.ijantimicag.2020.106118_bib0023", "volume": "35", "year": "2014" }, { "DOI": "10.1515/CCLM.1999.049", "article-title": "Lactoferrin: a multifunctional glycoprotein involved in the modulation of the inflammatory process", "author": "Baveye", "doi-asserted-by": "crossref", "first-page": "281", "journal-title": "Clin Chem Lab Med", "key": "10.1016/j.ijantimicag.2020.106118_bib0024", "volume": "37", "year": "1999" }, { "DOI": "10.2174/138161209788453202", "article-title": "Lactoferrin as a natural immune modulator", "author": "Actor", "doi-asserted-by": "crossref", "first-page": "1956", "journal-title": "Curr Pharm Des", "key": "10.1016/j.ijantimicag.2020.106118_bib0025", "volume": "15", "year": "2009" }, { "DOI": "10.3389/fimmu.2017.01438", "article-title": "Lactoferrin in a context of inflammation-induced pathology", "author": "Kruzel", "doi-asserted-by": "crossref", "first-page": "1438", "journal-title": "Front Immunol", "key": "10.1016/j.ijantimicag.2020.106118_bib0026", "volume": "8", "year": "2017" }, { "article-title": "Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis", "author": "Bone", "first-page": "1644", "key": "10.1016/j.ijantimicag.2020.106118_bib0027", "series-title": "The ACCP/SCCM Consensus Conference Committee", "volume": "101", "year": "1992" }, { "DOI": "10.1002/art.40071", "article-title": "Review: cytokine storm syndrome: looking toward the precision medicine era", "author": "Behrens", "doi-asserted-by": "crossref", "first-page": "1135", "journal-title": "Arthritis Rheumatol", "key": "10.1016/j.ijantimicag.2020.106118_bib0028", "volume": "69", "year": "2017" }, { "DOI": "10.1177/1753425909105317", "article-title": "Lactoferrin decreases LPS-induced mitochondrial dysfunction in cultured cells and in animal endotoxemia model", "author": "Kruzel", "doi-asserted-by": "crossref", "first-page": "67", "journal-title": "Innate Immun", "key": "10.1016/j.ijantimicag.2020.106118_bib0029", "volume": "16", "year": "2010" }, { "DOI": "10.1023/A:1006935908960", "article-title": "Lactoferrin protects gut mucosal integrity during endotoxemia induced by lipopolysaccharide in mice", "author": "Kruzel", "doi-asserted-by": "crossref", "first-page": "33", "journal-title": "Inflammation", "key": "10.1016/j.ijantimicag.2020.106118_bib0030", "volume": "24", "year": "2000" }, { "article-title": "Lactoferrin supplementation to prevent late-onset sepsis in preterm infants: a meta-analysis", "author": "Razak", "journal-title": "Am J Perinatol", "key": "10.1016/j.ijantimicag.2020.106118_bib0031", "year": "2019" }, { "DOI": "10.1097/CCM.0b013e3182741551", "article-title": "A phase 2 randomized, double-blind, placebo-controlled study of the safety and efficacy of talactoferrin in patients with severe sepsis", "author": "Guntupalli", "doi-asserted-by": "crossref", "first-page": "706", "journal-title": "Crit Care Med", "key": "10.1016/j.ijantimicag.2020.106118_bib0032", "volume": "41", "year": "2013" }, { "DOI": "10.1097/CCM.0000000000001090", "doi-asserted-by": "crossref", "key": "10.1016/j.ijantimicag.2020.106118_bib0033", "unstructured": "Vincent JL, Marshall JC, Dellinger RP, Simonson SG, Guntupalli K, Levy MM, et al. Talactoferrin in severe sepsis: results from the phase II/III Oral tAlactoferrin in Severe sepsis Trial. Crit Care Med201543:1832–8. doi:10.1097/CCM.0000000000001090." }, { "DOI": "10.1128/JVI.79.22.14451-14456.2005", "article-title": "Murine coronavirus with an extended host range uses heparan sulfate as an entry receptor", "author": "de Haan", "doi-asserted-by": "crossref", "first-page": "14451", "journal-title": "J Virol", "key": "10.1016/j.ijantimicag.2020.106118_bib0034", "volume": "79", "year": "2005" }, { "DOI": "10.1128/JVI.02078-14", "doi-asserted-by": "crossref", "key": "10.1016/j.ijantimicag.2020.106118_bib0035", "unstructured": "Milewska A, Zarebski M, Nowak P, Stozek K, Potempa J, Pyrc K. Human coronavirus NL63 utilizes heparan sulfate proteoglycans for attachment to target cells. J Virol201488:13221–30. doi:10.1128/jvi.02078-14." }, { "DOI": "10.1371/journal.ppat.1000621", "doi-asserted-by": "crossref", "key": "10.1016/j.ijantimicag.2020.106118_bib0036", "unstructured": "Burckhardt CJ, Greber UF.Virus movements on the plasma membrane support infection and transmission between cells. PLoS Pathog20095:e1000621. doi:10.1371/journal.ppat.1000621." }, { "DOI": "10.1016/j.cell.2020.02.052", "article-title": "SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor", "author": "Hoffmann", "doi-asserted-by": "crossref", "journal-title": "Cell", "key": "10.1016/j.ijantimicag.2020.106118_bib0037", "volume": "181", "year": "2020" }, { "DOI": "10.5530/ijrhs.8.1.3", "article-title": "Liposomal lactoferrin as potential prevention and cure for COVID-19", "author": "Serrano", "doi-asserted-by": "crossref", "first-page": "8", "journal-title": "Int J Res Health Sci", "key": "10.1016/j.ijantimicag.2020.106118_bib0038", "volume": "8", "year": "2020" }, { "DOI": "10.1016/S0140-6736(20)30628-0", "article-title": "COVID-19: consider cytokine storm syndromes and immunosuppression", "author": "Mehta", "doi-asserted-by": "crossref", "first-page": "1033", "journal-title": "Lancet", "key": "10.1016/j.ijantimicag.2020.106118_bib0039", "volume": "395", "year": "2020" }, { "article-title": "Lactoferrin lowers serum interleukin 6 and tumor necrosis factor alpha levels in mice subjected to surgery", "author": "Zimecki", "first-page": "97", "journal-title": "Arch Immunol Ther Exp (Warsz)", "key": "10.1016/j.ijantimicag.2020.106118_bib0040", "volume": "46", "year": "1998" }, { "DOI": "10.3390/ijms18091985", "article-title": "Lactoferrin: a natural glycoprotein involved in iron and inflammatory homeostasis", "author": "Rosa", "doi-asserted-by": "crossref", "first-page": "1985", "journal-title": "Int J Mol Sci", "key": "10.1016/j.ijantimicag.2020.106118_bib0041", "volume": "18", "year": "2017" }, { "DOI": "10.1248/bpb.28.1717", "article-title": "Liposomalization of lactoferrin enhanced it's anti-inflammatory effects via oral administration", "author": "Ishikado", "doi-asserted-by": "crossref", "first-page": "1717", "journal-title": "Biol Pharm Bull", "key": "10.1016/j.ijantimicag.2020.106118_bib0042", "volume": "28", "year": "2005" }, { "DOI": "10.1016/j.pedneo.2020.03.001", "article-title": "Clinical characteristics of novel coronavirus disease 2019 (COVID-19) in newborns, infants and children", "author": "Hong", "doi-asserted-by": "crossref", "first-page": "131", "journal-title": "Pediatr Neonatol", "key": "10.1016/j.ijantimicag.2020.106118_bib0043", "volume": "61", "year": "2020" }, { "DOI": "10.1001/jama.2020.2131", "article-title": "Novel coronavirus infection in hospitalized infants under 1 year of age in China", "author": "Wei", "doi-asserted-by": "crossref", "first-page": "1313", "journal-title": "JAMA", "key": "10.1016/j.ijantimicag.2020.106118_bib0044", "volume": "323", "year": "2020" }, { "DOI": "10.1007/s004300050093", "article-title": "Inhibition of poliovirus type 1 infection by iron-, manganese- and zinc-saturated lactoferrin", "author": "Marchetti", "doi-asserted-by": "crossref", "first-page": "199", "journal-title": "Med Microbiol Immunol", "key": "10.1016/j.ijantimicag.2020.106118_bib0045", "volume": "187", "year": "1999" }, { "DOI": "10.1002/jmv.25707", "article-title": "Potential interventions for novel coronavirus in China: a systematic review", "author": "Zhang", "doi-asserted-by": "crossref", "first-page": "479", "journal-title": "J Med Virol", "key": "10.1016/j.ijantimicag.2020.106118_bib0046", "volume": "92", "year": "2020" } ], "reference-count": 46, "references-count": 46, "relation": {}, "resource": { "primary": { "URL": "https://linkinghub.elsevier.com/retrieve/pii/S0924857920303010" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [ "Pharmacology (medical)", "Infectious Diseases", "Microbiology (medical)", "General Medicine" ], "subtitle": [], "title": "Lactoferrin as potential preventative and adjunct treatment for COVID-19", "type": "journal-article", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "volume": "56" }